Fertile Field for California's Stem Cell/Gene Therapy Story: Can It Measure Up?
National turmoil over research in sharp contrast to operations of California Institute for Regenerative Medicine
It’s hard to believe, but President Trump is presenting a “beautiful” opportunity to California’s $12 billion stem cell and gene therapy program.
The Trumpian turmoil in Washington gives the research program, which lives and dies on California voter approval, a chance to tout its scientific prowess and its consistent financial support of research.
It’s a rare opportunity to compare what is going on in the nation’s capital to what is going on in the South San Francisco headquarters of the California Institute for Regenerative Medicine (CIRM), the official name of the stem cell agency.
Every year, close to $500 million flows smoothly out of CIRM’s doors for research aimed at developing revolutionary therapies.
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.